Free Trial
NASDAQ:ICCC

ImmuCell (ICCC) Stock Price, News & Analysis

ImmuCell logo
$6.05 -0.20 (-3.20%)
Closing price 10/17/2025 03:49 PM Eastern
Extended Trading
$6.05 0.00 (0.00%)
As of 10/17/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ImmuCell Stock (NASDAQ:ICCC)

Advanced

Key Stats

Today's Range
$6.06
$6.35
50-Day Range
$5.65
$6.80
52-Week Range
$3.38
$7.60
Volume
8,929 shs
Average Volume
22,608 shs
Market Capitalization
$54.75 million
P/E Ratio
31.84
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

Receive ICCC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmuCell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ICCC Stock News Headlines

Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enforcing that means a $5.39 billion pot must be paid out to everyday Americans. See, virtually every AI model is built off stolen data...tc pixel
Immucell Appoints New CEO Olivier te Boekhorst
See More Headlines

ICCC Stock Analysis - Frequently Asked Questions

ImmuCell's stock was trading at $5.15 at the beginning of the year. Since then, ICCC stock has increased by 17.5% and is now trading at $6.05.

ImmuCell Corporation (NASDAQ:ICCC) announced its quarterly earnings results on Thursday, August, 14th. The biotechnology company reported $0.06 EPS for the quarter. The biotechnology company had revenue of $6.45 million for the quarter. ImmuCell had a trailing twelve-month return on equity of 6.25% and a net margin of 6.23%.
Read the conference call transcript
.

Shares of ICCC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmuCell investors own include VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), Altimmune (ALT), Biocept (BIOC), ImmunoGen (IMGN), Novavax (NVAX) and Pfizer (PFE).

Company Calendar

Last Earnings
8/14/2025
Today
10/19/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ICCC
CIK
811641
Employees
70
Year Founded
1982

Profitability

EPS (Trailing Twelve Months)
$0.19
Trailing P/E Ratio
31.84
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$2.16 million
Net Margins
6.23%
Pretax Margin
6.27%
Return on Equity
6.25%
Return on Assets
3.87%

Debt

Debt-to-Equity Ratio
0.28
Current Ratio
3.85
Quick Ratio
1.99

Sales & Book Value

Annual Sales
$26.49 million
Price / Sales
2.07
Cash Flow
$0.06 per share
Price / Cash Flow
94.25
Book Value
$3.09 per share
Price / Book
1.96

Miscellaneous

Outstanding Shares
9,050,000
Free Float
8,539,000
Market Cap
$54.75 million
Optionable
Not Optionable
Beta
0.30

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:ICCC) was last updated on 10/19/2025 by MarketBeat.com Staff
From Our Partners